Gene: BTG2
Official Full Name: BTG anti-proliferation factor 2provided by HGNC
Gene Summary: The protein encoded by this gene is a member of the BTG/Tob family. This family has structurally related proteins that appear to have antiproliferative properties. This encoded protein is involved in the regulation of the G1/S transition of the cell cycle. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO34438 | BTG2 Knockout cell line (HeLa) | Human | BTG2 | 1:3~1:6 | Negative | Online Inquiry |
KO34439 | BTG2 Knockout cell line (HCT 116) | Human | BTG2 | 1:2~1:4 | Negative | Online Inquiry |
KO34440 | BTG2 Knockout cell line (HEK293) | Human | BTG2 | 1:3~1:6 | Negative | Online Inquiry |
KO34441 | BTG2 Knockout cell line (A549) | Human | BTG2 | 1:3~1:4 | Negative | Online Inquiry |
BTG2 Gene Knockout Cell Lines represent a sophisticated biotechnological tool developed for in-depth investigation of the BTG2 gene's role in cellular processes. BTG2 (B-cell Translocation Gene 2) is implicated in cell cycle regulation, apoptosis, and differentiation, making it a vital subject of study in cancer biology and therapeutic development. Our knockout cell lines provide researchers with a genetically modified system where the BTG2 gene is selectively disrupted, enabling precise assessment of the gene's functions and its impact on cellular pathways.
The key function of these cell lines lies in their ability to mimic conditions of BTG2 gene silencing, which facilitates the analysis of downstream effects on gene expression, protein interactions, and cell behavior. This knockout model allows for advanced experimentation, including drug response studies, functional assays, and phenotypic characterization. Beyond basic research, these cell lines are invaluable in investigating the therapeutic potential of targeting the BTG2 pathway in cancers and other diseases where its expression is altered.
One of the main advantages of our BTG2 Gene Knockout Cell Lines is their high specificity and reliability compared to traditional methods such as CRISPR/Cas9, which may cause off-target effects. Our cell lines undergo rigorous validation to ensure precise gene knockout, reducing variability in experimental outcomes. Additionally, these lines are readily accessible and easy to incorporate into existing research workflows, promoting efficiency without compromising scientific integrity.
For researchers and clinicians, utilizing BTG2 Gene Knockout Cell Lines can accelerate the understanding of key cellular mechanisms and enhance the discovery of potential therapeutic interventions. The accumulation of insights gained through the use of these cell lines could indeed pave the way for novel strategies in cancer treatments and beyond.
With a commitment to cutting-edge research and development, our company specializes in providing high-quality biological products. Our expertise in genetic engineering ensures that researchers have access to reliable and scientifically validated tools that empower their investigations, driving innovation in the life sciences field.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.